Reprocessing Effectiveness for Flexible Ureteroscopes: A Critical Look at the Evidence - 13/06/22

Abstract |
Flexible ureteroscopes are essential devices, and reusable models require meticulous cleaning and sterilization between procedures. Reprocessing is complex, time-consuming, and difficult due to the instrument's small size, fragility, and internal channel. The Food and Drug Administration recently raised concerns about the effectiveness of ureteroscope reprocessing. Due to inadequate reprocessing and maintenance, contaminated and damaged ureteroscopes pose risks to patient safety. This review describes ureteroscope reprocessing methods and summarizes evidence on reprocessing effectiveness and documented outcomes associated with the use of damaged or inadequately cleaned and sterilized ureteroscopes.
Le texte complet de cet article est disponible en PDF.Abbreviations : FDA, IFU, fURS, AUA, MDR, CFU
Plan
| Financial Disclosures: This manuscript was supported in part by an unrestricted research grant from Boston Scientific Corporation (BSC). BSC was not involved in developing our research approach, compiling or analyzing data, interpreting results, or preparing the manuscript, and did not receive a copy of this manuscript for review prior to submission. CLO, KMH, AGS, JEE, and HPW have received research grants, study materials, educational materials, or consulting contracts from 3M Company, Ambu, Auris Health, Advanced Sterilization Products, Boston Scientific Corporation, Cantel/Medivators, Convergascent, Fortive, Healthmark, Laborie/Cogentix, Pentax, and Steris. SKB is a consultant for Boston Scientific, Ambu, Olympus Medical, Auris Health, and Intuitive, and an educator/speaker for Karl Storz, Cook, and Travere. |
Vol 164
P. 25-32 - juin 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
